Related Experiment Video

Updated: Aug 19, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

Effect of octreotide in the prevention of doxorubicin cardiotoxicity

Cem Barçin1, Hürkan Kurşaklioğlu, Mükerrem Safali

  • 1Department of Cardiology, Gulhane Military Medical Academy, Ankara, Turkey. cembarcin@yahoo.com

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|March 10, 2005
PubMed
Abstract

Insights

Octreotide did not significantly prevent doxorubicin cardiotoxicity in rabbits. However, a trend towards reduced cardiac damage was observed, warranting further investigation into its potential protective mechanisms.

Area of Science:

  • Cardiology
  • Pharmacology
  • Oncology

Background:

  • Doxorubicin is a widely used chemotherapy agent with known cardiotoxic side effects.
  • Effective strategies for preventing doxorubicin-induced cardiotoxicity remain an unmet clinical need.
  • Octreotide, a somatostatin analog, has been explored for various therapeutic applications.

Purpose of the Study:

  • To investigate the potential protective effect of octreotide against doxorubicin-induced cardiotoxicity.
  • To evaluate the impact of octreotide co-administration on cardiac function and structure in a rabbit model.

Main Methods:

  • New Zealand rabbits were divided into four groups: doxorubicin + octreotide, doxorubicin alone, octreotide alone, and saline control.
  • Cardiac function was assessed by measuring fractional shortening (FS) and QTc interval.
  • Histopathological scoring was used to evaluate the extent of cardiotoxicity.

Main Results:

  • Doxorubicin administration led to significant QTc interval prolongation and a decrease in fractional shortening.
  • While octreotide co-administration showed a trend towards reduced cardiotoxicity, only the difference in the rate of decrease in FS was statistically significant compared to doxorubicin alone.
  • No significant changes in cardiac parameters were observed in the octreotide-only or saline groups.

Conclusions:

  • Octreotide did not demonstrate a significant protective effect against doxorubicin cardiotoxicity in this preliminary study.
  • A consistent tendency towards decreased cardiotoxicity was observed in the group receiving both octreotide and doxorubicin.
  • Further research is required to elucidate the extent and mechanisms of octreotide's potential effect on doxorubicin-induced cardiac damage.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...